ACHE and early-onset autosomal dominant Alzheimer disease: However, in patients with moderate-to-severe Alzheimer’s disease, continued treatment with donepezil showed minimal benefit [17]; therefore, the efficacy of this acetylcholinesterase inhibitor in the treatment of Alzheimer’s disease remains controversial [18].